Trade names from 'Voltaren®' to 'Vulnuzan®' - Electronic medicinal guide TALKDRUGS

Transdermal patch, 30 mg / day (area 140 cm2).

Spray for external use dosed with 8 mg / dose.
Suppositories rectal, 25 mg, 50 mg or 100 mg.
Novartis Pharma AG Switzerland
Tablets coated with enteric coating, 25 mg or 50 mg.
Tablets of prolonged action, film-coated, 100 mg.
Novartis Pharma AG Switzerland
Solution for intramuscular injection 25 mg / ml.
Novartis Pharma AG Switzerland

Transdermal patch, 15 mg / day (area 70 cm2).

Tablets, film-coated 12.5 mg.
Tablets, coated with a coating, 50 mg.
Novartis Pharma AG Switzerland
Powder for solution for oral administration, 50 mg.
Novartis Pharma AG Switzerland

Gel for external use, 1%.

Gel for external use, 2%.
Capsules, 75 mg.
Novartis Pharma AG Switzerland

Solution for infusion, 6%.

Solution for infusion.
Tablets coated with a film coating, 50 mg and 200 mg.
Liofilizate for the preparation of concentrate for the preparation of a solution for infusion 200 mg.

Tablets coated with a film coating, 50 mg and 200 mg.

Tablets coated with a film coating, 50 mg and 200 mg.
Sandoz d. Slovenia

Tablets coated with a film coating, 50 mg and 200 mg.

Tablets, film-coated, 50 mg, 200 mg.
Tablets of 100 mg.

The film-coated tablets are 200 mg and 400 mg.

Novartis Pharma AG Switzerland

Lyophilizate for solution for infusion.

Shayer AG Switzerland
Capsules 30 mg, 40 mg.
Ointment for local and external use.


Sopharma, AO Bulgaria